Talha Munir, Keri Yang, Leyla Mohseninejad, Sheng Xu, Pal Rakonczai, Balazs Dobi, Rhys Williams, Nicolas Martinez-Calle. "Efficacy of continuous zanubrutinib vs fixed-duration venetoclax in combination with obinutuzumab in treatment-naive (TN) chronic lymphocytic leukemia (CLL): A matching-adjusted indirect comparison (MAIC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e19027